Pharmalittle: We're reading about another FDA reversal, pharma's M&A spree and much more statnews.com
Summary generated by RabbitReport AI from public reporting. The full article and original reporting belong to statnews.com.
West Virginia political figures Senator Shelley Moore Capito and Governor Jim Justice are being questioned on their ability to deliver on promises to reduce prescription drug prices. This focus on drug pricing reflects ongoing political pressure within the pharmaceutical sector to address rising costs for consumers. The situation highlights the intersection of state-level leadership and broader industry pricing challenges.
June 22, 2026Moderna’s mRNA-based influenza vaccine candidate has successfully passed a review by the U.S. Food and Drug Administration's (FDA) Advisory Committee (AdCom). This milestone marks a significant step forward for the application of messenger RNA technology beyond COVID-19 and into the seasonal respiratory virus market. The ongoing regulatory review will determine if this candidate becomes the first mRNA flu vaccine to reach the commercial market, potentially disrupting the traditional egg-based manufacturing landscape.
June 22, 2026Regulatory authorities in Australia and the Philippines are introducing new measures to tighten pharmaceutical advertising and incentivize domestic drug manufacturing. The Australian Therapeutic Goods Administration (TGA) has clarified its ban on prescription drug promotion, targeting trade names, chemical names, and indirect imagery in marketing materials. Meanwhile, the Philippine FDA is consulting on a fast-track registration process for locally produced medicines to reduce reliance on imports and support national health policy goals.
June 22, 2026Engineers at Purdue University have tested and validated a novel method aimed at improving pharmaceutical research and development. The initiative focuses on enhancing the efficiency of the R&D process, which is a critical area for drug manufacturers looking to optimize product pipelines. This development represents a potential step forward in academic contributions to industrial pharmaceutical engineering and process validation.
June 22, 2026